Gulfo Sees FDA Getting `Back on Track' on Melanoma Test: Video
May 20 (Bloomberg) -- Joseph Gulfo, chief executive officer of Mela Sciences Inc., talks about the U.S. Food and Drug Administration's delay in approving its melanoma-detection device. Mela filed a first-of-its-kind petition to force the agency to uphold an agreement to approve the device. Gulfo speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
Joseph Gulfo, chief executive officer of Mela Sciences Inc., talks about the U.S. Food and Drug Administration's delay in approving its melanoma-detection device.
Mela filed a first-of-its-kind petition to force the agency to uphold an agreement to approve the device. Gulfo speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
Running time 05:09
Rate this Page